From: Integrated analysis of microRNA-target interactions with clinical outcomes for cancers
 | Num of Significant Pairs (p-value < 0.01) | HH:LL | HL:LH | HH:HL | HH:LH | LL:LH | LL:HL |
---|---|---|---|---|---|---|---|
Ovarian Cancer | Validation Pair | 257 | 261 | 113 | 200 | 143 | 248 |
 | Total Pair | 22,685 | 22,575 | 9,408 | 18,739 | 10,299 | 21,332 |
GBM | Validation Pair | 234 | 250 | 229 | 171 | 161 | 229 |
 | Total Pair | 47,706 | 51,217 | 22,180 | 36,023 | 22,835 | 42,735 |